ERBB2 and non-small cell lung carcinoma: Human epidermal growth factor receptor 2 (HER2) alterations, including exon 20 insertions and gene amplification, are detected in a small subset of NSCLC patients, with mutations found in approximately 2-4% and amplification occurring in about 2-5% of cases.